CYT003-QbG10, a TLR9-agonist, for Treatment of Uncontrolled Moderate to Severe Allergic Asthma
Clinical trial NCT01673672 · TERMINATED
Trial details
- NCT number
- NCT01673672
- Sponsor
- Cytos Biotechnology AG
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2014-05-01
- Enrollment
- 365
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.